349
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Gut microbiota dysbiosis contributes to the development of hypertension

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Recently, the potential role of gut microbiome in metabolic diseases has been revealed, especially in cardiovascular diseases. Hypertension is one of the most prevalent cardiovascular diseases worldwide, yet whether gut microbiota dysbiosis participates in the development of hypertension remains largely unknown. To investigate this issue, we carried out comprehensive metagenomic and metabolomic analyses in a cohort of 41 healthy controls, 56 subjects with pre-hypertension, 99 individuals with primary hypertension, and performed fecal microbiota transplantation from patients to germ-free mice.

          Results

          Compared to the healthy controls, we found dramatically decreased microbial richness and diversity, Prevotella-dominated gut enterotype, distinct metagenomic composition with reduced bacteria associated with healthy status and overgrowth of bacteria such as Prevotella and Klebsiella, and disease-linked microbial function in both pre-hypertensive and hypertensive populations. Unexpectedly, the microbiome characteristic in pre-hypertension group was quite similar to that in hypertension. The metabolism changes of host with pre-hypertension or hypertension were identified to be closely linked to gut microbiome dysbiosis. And a disease classifier based on microbiota and metabolites was constructed to discriminate pre-hypertensive and hypertensive individuals from controls accurately. Furthermore, by fecal transplantation from hypertensive human donors to germ-free mice, elevated blood pressure was observed to be transferrable through microbiota, and the direct influence of gut microbiota on blood pressure of the host was demonstrated.

          Conclusions

          Overall, our results describe a novel causal role of aberrant gut microbiota in contributing to the pathogenesis of hypertension. And the significance of early intervention for pre-hypertension was emphasized.

          Electronic supplementary material

          The online version of this article (doi:10.1186/s40168-016-0222-x) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

          The Lancet, 380(9859), 2224-2260
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease.

            There is substantial inter-individual diversity in the susceptibility of alcoholics to liver injury. Alterations of intestinal microbiota (IM) have been reported in alcoholic liver disease (ALD), but the extent to which they are merely a consequence or a cause is unknown. We aimed to demonstrate that a specific dysbiosis contributes to the development of alcoholic hepatitis (AH).
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials.

              Previous human clinical trials have shown that probiotic consumption may improve blood pressure (BP) control. The aim of the present systematic review was to clarify the effects of probiotics on BP using a meta-analysis of randomized, controlled trials. PubMed, Scopus, Cochrane Library (Central), Physiotherapy Evidence Database, and Clinicaltrial.gov databases were searched until January 2014 to identify eligible articles. Meta-analysis using a random-effects model was chosen to analyze the impact of combined trials. Nine trials were included. Probiotic consumption significantly changed systolic BP by -3.56 mm Hg (95% confidence interval, -6.46 to -0.66) and diastolic BP by -2.38 mm Hg (95% confidence interval, -2.38 to -0.93) compared with control groups. A greater reduction was found with multiple as compared with single species of probiotics, for both systolic and diastolic BP. Subgroup analysis of trials with baseline BP ≥130/85 mm Hg compared with <130/85 mm Hg found a more significant improvement in diastolic BP. Duration of intervention <8 weeks did not result in a significant reduction in systolic or diastolic BP. Furthermore, subgroup analysis of trials with daily dose of probiotics <10(11) colony-forming units did not result in a significant meta-analysis effect. The present meta-analysis suggests that consuming probiotics may improve BP by a modest degree, with a potentially greater effect when baseline BP is elevated, multiple species of probiotics are consumed, the duration of intervention is ≥8 weeks, or daily consumption dose is ≥10(11) colony-forming units. © 2014 American Heart Association, Inc.
                Bookmark

                Author and article information

                Contributors
                lijing11999@126.com
                zhfq@biols.ac.cn
                ada8811@126.com
                chenjunru@novogene.com
                15232728075@163.com
                gangtian36@163.com
                drwusl@163.com
                liuwenbin@novogene.com
                cuiqinghua@bjmu.edu.cn
                bingeng@bjmu.edu.cn
                zhangweili1747@yahoo.com
                rweldon90@gmail.com
                kelda.auguste@gmail.com
                yl6649084@163.com
                lxy-213@163.com
                lchen6@uh.edu
                86-10-85231937 , yxc6229@sina.com
                zhubaoli@im.ac.cn
                86-10-88398530 , caijun@fuwaihospital.org
                Journal
                Microbiome
                Microbiome
                Microbiome
                BioMed Central (London )
                2049-2618
                1 February 2017
                1 February 2017
                2017
                : 5
                : 14
                Affiliations
                [1 ]ISNI 0000 0000 9889 6335, GRID grid.413106.1, , Hypertension Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease of China, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, ; Beijing, 100037 China
                [2 ]ISNI 0000 0004 0369 153X, GRID grid.24696.3f, Department of Cardiology, , Beijing ChaoYang Hospital, Capital Medical University, ; Beijing, 100020 China
                [3 ]Beijing Key Laboratory of Hypertension, Beijing, 100020 China
                [4 ]ISNI 0000000119573309, GRID grid.9227.e, , Computational Genomics Laboratory, Beijing Institutes of Life Science, Chinese Academy of Sciences, ; Beijing, 100101 China
                [5 ]GRID grid.410753.4, , Novogene Bioinformatics Institute, ; Beijing, 100000 China
                [6 ]Department of Cardiology, Baoding NO.1 Central Hospital, Baoding, 071000 China
                [7 ]ISNI 0000 0001 0599 1243, GRID grid.43169.39, Department of Cardiology, The First Affiliated Hospital, , Xi’an Jiaotong University, ; Xi’an, 710061 China
                [8 ]Department of Cardiology Kailuan General Hospital, Hebei Union University, Tangshan, 063000 China
                [9 ]ISNI 0000 0001 2256 9319, GRID grid.11135.37, Department of Biomedical Informatics, Centre for Noncoding RNA Medicine, School of Basic Medical Sciences, , Peking University, ; Beijing, 100191 China
                [10 ]ISNI 0000 0004 1569 9707, GRID grid.266436.3, Department of Biology and Biochemistry, , University of Houston, ; Houston, TX 77204 USA
                [11 ]ISNI 0000 0004 0369 153X, GRID grid.24696.3f, Medical Research Center, Beijing ChaoYang Hospital, , Capital Medical University, ; Beijing, 100020 China
                [12 ]ISNI 0000 0001 2296 6154, GRID grid.416986.4, Department of Stem Cell Engineering, , Texas Heart Institute, ; Houston, TX 77030 USA
                [13 ]Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430030 China
                [14 ]ISNI 0000000119573309, GRID grid.9227.e, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, , Chinese Academy of Sciences, ; Beijing, 100101 China
                [15 ]ISNI 0000 0004 1759 700X, GRID grid.13402.34, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, , College of Medicine, Zhejiang University, ; Hangzhou, 310003 China
                Article
                222
                10.1186/s40168-016-0222-x
                5286796
                28143587
                5c5f4c86-ec4d-4804-8f45-ab39f1b07d66
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 25 July 2016
                : 13 December 2016
                Funding
                Funded by: National Basic Research Program of China
                Award ID: 2014CB542302
                Award ID: 2015CB554200
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 81500383
                Award ID: 81630014
                Award Recipient :
                Funded by: AHA Scientist Development Grant
                Award ID: 12SDG11680011
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2017

                hypertension,pre-hypertension,gut microbiota,metabolism,fecal transplant

                Comments

                Comment on this article